home primaryabout corporate profile global locations executive management board of directors medical education grants medicines overview actimmune buphenyl duexis krystexxa migergot pennsaid ravicti rayos vimovo patients overview horizoncares overview co pay assistance patient assistance program retail programs patient resources diseases arthritis pain and inflammation osteoarthritis rheumatoid arthritis polymyalgia rheumatica ankylosing spondylitis rare diseases chronic granulomatous disease severe malignant osteopetrosis urea cycle disorders resources arthritis pain and inflammation rare diseases news press releases events corporate fact sheet media contact media resources investors overview press releases events & presentations corporate governance financial information stock information annual reports investor faqs contact us email alerts business development overview transactions careers contact global locations medicine support return to content innovative therapies for life as a global biopharmaceutical company focused on providing innovative therapies horizon pharma helps people live better lives . horizon in the news horizon pharma plc to acquire raptor pharmaceutical corp. as further step in building leading rare disease business learn more privacy policy privacy shield policy legal notice all rights reserved 2016 horizon pharma plc home medicines patients news investors business development careers contact sitemap search 2016 horizon pharma . all rights reserved . powered by wordpress . designed by